Morenike AyoVaughan

Morenike Ayo-Vaughan advises clients within the field of healthcare quality measurement and improvement.

Morenike has experience in workflow design, health information technology management, health policy research, and hospital administration.

Prior to joining Avalere, Morenike was a practice operations associate for Privia Health, creating the framework for CMS Meaningful Use program participation for multi-specialty providers and conducting analysis to examine the effectiveness of population health interventions on patients’ outcomes and company revenue. Prior to that, as a Lean Six Sigma consultant to the Lombardi Cancer Center, she performed analysis and made recommendations around patient clinical experiences.Morenike has an MS in health systems administration from Georgetown University and a BS in public health from Temple University.

Authored Content

Reducing health disparities is critical to advancing health equity, and each stakeholder has a role to play.

Avalere Health and Sick Cells have published a strategic roadmap, intended to advance care for individuals with sickle cell disease (SCD). The roadmap includes consensus-based solutions that various healthcare stakeholders can implement in the near future.

With support from the Robert Wood Johnson Foundation, Avalere assesses opportunities to normalize cost-of-care conversations through measurement.

Sickle cell disease (SCD) is a severe red blood cell disorder that disproportionately affects African-American and Hispanic populations. In the United States, there are approximately 100,000 individuals living with SCD (although there is a lack of accurate reporting and the exact number is unknown).

On July 9, Health & Human Services (HHS) announced the formation of the Quality Summit (QS), as directed by a recent executive order aimed at improving price and quality transparency.

In January 2018, Avalere Health partnered with the Society of Cardiovascular and Angiography Interventions to launch the development of the Heart Valve Initiative.